RxDoctor Payments Data

Olivia Taylor

Psychiatric/Mental Health · Jasper, INNPI 1255888475

Payments from drug & device makers

$546in general payments, 2019–2025

Across 28 payments — averaging $19.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$110
  • AbbVie$57
  • Takeda Pharmaceuticals U.S.A., Inc.$49
  • Vanda Pharmaceuticals Inc.$43
  • Teva Pharmaceuticals USA, Inc.$41
  • Alkermes, Inc.$34
  • plus $210 from 8 others

What the payments were for

  • Food & beverage$546100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$546 in reported general payments places this provider in the 45th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$19,929
Medicare patients
50
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole12$16,269
TrintellixVortioxetine Hydrobromide13$6,859
VyvanseLisdexamfetamine Dimesylate11$4,106
Aripiprazole41$3,677
Desvenlafaxine Succinate ErDesvenlafaxine Succinate46$3,049
Perphenazine14$2,913
Paliperidone ErPaliperidone23$2,509
Clozapine31$1,487
Vilazodone Hcl13$1,309
Buspirone Hcl62$773
Bupropion XlBupropion Hcl24$751
Quetiapine Fumarate40$544
Mirtazapine32$488
Duloxetine Hcl15$435
Trazodone Hcl54$431

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti$19$16,26912 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse$49$10,96524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Jasper

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →